1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY
2.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET

3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT

4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW- BY CHEMISTRY TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY  CHEMISTRY TYPE
4.1.1.1 ANIMAL BASED
4.1.1.2 PLANT BASED
4.1.1.3 MINERAL
4.1.1.4 SYNTHETIC

5 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
5.1.1.1 FATTY ALCOHOLS
5.1.1.2 GLYCERIN
5.1.1.3 SUGAR ALCOHOLS
5.1.1.4 STARCH
5.1.1.5 OTHERS

6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FORMULATION TYPE
6.1 INTRODUCTION
6.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FORMULATION TYPE
6.1.1.1 ORAL
6.1.1.2 PARENTERAL
6.1.1.3 OTHERS

7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FUNCTIONALITY
7.1 INTRODUCTION
7.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FUNCTIONALITY
7.1.1.1 BINDERS
7.1.1.2 GLIDANTS
7.1.1.3 DISINTEGRANT
7.1.1.4 OTHERS

8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
8.1 INTRODUCTION
8.2 KEY TAKEWAYS

9 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
9.3 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
9.4 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
9.5 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
9.6 U.S.
9.7 CANADA
9.8 MEXICO

10 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
10.3 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
10.4 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
10.5 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
10.6 U.K.
10.7 FRANCE
10.8 GERMANY
10.9 ITALY
10.10 SPAIN
10.11 REST OF EUROPE

11 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
11.3 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
11.4 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
11.5 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
11.6 INDIA
11.7 CHINA
11.8 JAPAN
11.9 REST OF ASIA PACIFIC

12 MIDDLE EAST AND AFRICA (MEA) PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
12.3 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
12.4 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
12.5 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
12.6 SOUTH AFRICA
12.7 REST OF MIDDLE EAST AND AFRICA

13 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
13.1 MARKET DYNAMICS
13.1.1 DRIVERS
13.1.2 RESTRAINTS
13.1.3 OPPORTUNITIES
13.2 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
13.3 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
13.4 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
13.5 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
13.6 BRAZIL
13.7 REST OF LATIN AMERICA

14 COMPETATIVE LANDSCAPE
14.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-COMPANY MARKET SHARE ANALYSIS

15 COMPANY PROFILES: (REVENUE,  CHEMISTRY TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
15.1 ADNAGEN AG
15.2 AVIVA BIOSCIENCES
15.3 BIOCEP LTD.
15.4 BIOFLUIDICA MICROTECHNOLOGIES LLC
15.5 EVONIK INDUSTRIES AG
15.6 FMC CORPORATION
15.7 INNOPHOS HOLDINGS INC.
15.8 THE LUBRIZOL CORPORATION
15.9 ROQUETTE GROUP
15.10 SIGNET